Role of Topical Treatments in the Modulation of Skin Microbiome in Psoriatic Skin

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 24, 2018

Primary Completion Date

September 24, 2018

Study Completion Date

March 7, 2019

Conditions

Psoriasis Vulgaris

Interventions

DRUG

Betamethasone-Calcipotriene Topical

Comparison between betamethasone-calcipotriol and placebo

DRUG

Betamethasone-Calcipotriene Topical

Comparison between betamethasone-calcipotriol and betamethasone

DRUG

Betamethasone-Calcipotriene Topical

Comparison between betamethasone-calcipotriol and propionate de clobetasol

Trial Locations (1)

CHU de Nice, Nice

All Listed Sponsors

lead

Centre Hospitalier Universitaire de Nice

OTHER

NCT03584360 - Role of Topical Treatments in the Modulation of Skin Microbiome in Psoriatic Skin | Biotech Hunter | Biotech Hunter